Simultaneous occurrence of large B-cell non-Hodgkin lymphoma and acute myeloid leukaemia in an elderly patient: complete remissions of both diseases by rituximab-bendamustine regimen combined to hypomethylating therapy

J Chemother. 2013 Aug;25(4):247-9. doi: 10.1179/1973947813Y.0000000076.

Abstract

The case of an elderly and frail patient affected by simultaneous large B-cell non-Hodgkin lymphoma and acute myeloid leukaemia is reported. The complete remissions of both diseases by azacitidine and rituximab-bendamustine regimen were achieved.

Publication types

  • Case Reports

MeSH terms

  • Aged, 80 and over
  • Antibodies, Monoclonal, Murine-Derived / administration & dosage
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Azacitidine / administration & dosage
  • Bendamustine Hydrochloride
  • Female
  • Frail Elderly
  • Humans
  • Leukemia, Myeloid, Acute / drug therapy*
  • Leukemia, Myeloid, Acute / pathology
  • Lymphoma, Large B-Cell, Diffuse / drug therapy*
  • Lymphoma, Large B-Cell, Diffuse / pathology
  • Nitrogen Mustard Compounds / administration & dosage
  • Remission Induction
  • Rituximab

Substances

  • Antibodies, Monoclonal, Murine-Derived
  • Nitrogen Mustard Compounds
  • Rituximab
  • Bendamustine Hydrochloride
  • Azacitidine